Clinical Trial Update: A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors [Phase 1]

View source ↗

Summary

A Phase I study evaluating SPGL008 in patients with advanced malignant tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• SPGL008

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Advanced Malignant Tumors | Phase 1 | Status: RECRUITING